Alpha-1-antitrypsin for the improvement of autoimmunity and allograft rejection in beta cell transplantation

Immunology Letters

Volumn 150, Issue 1-2, 2013, Pages 61-68

  Ye, Jian ^a   Liao, Yu Ting ^a   Jian, You Qiang ^a   Zhang, Xiao Dan ^a   Wei, Pei ^a   Qi, Hui ^a   Deng, Chun Yan ^a   Li, Fu Rong ^a,b  

^a JINAN UNIVERSITY   (China)

^b Shenzhen Institute of Gerontology   (China)

Author keywords

1 Antitrypsin; Cell transplantation; Immune tolerance; Non obese diabetic mice; Type 1 diabetes

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL BASED GENE THERAPY; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GRAFT REJECTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ALPHA 1-ANTITRYPSIN; ANIMALS; APOPTOSIS; AUTOIMMUNITY; CELL LINE; CYTOKINES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84874522014     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.01.009     Document Type: Article

References (36)

1. Rossini A.A., Mordes J.P., Like A.A. Immunology of insulin-dependent diabetes mellitus. Annu Rev Immunol 1985, 3:289-320.
2. Couzin J. Diabetes - islet transplants face test of time. Science 2004, 306:34-37.
3. Kobayashi N., Okitsu T., Lakey J.R.T., Tanaka N. The current situation in human pancreatic islet transplantation: problems and prospects. J Artif Organ 2004, 7:1-8.
4. Shapiro A.M.J., Ricordi C., Hering B.J., Auchincloss H., Lindblad R., Robertson P., et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006, 355:1318-1330.
5. Balamurugan A.N., Bottino R., Giannoukakis N., Smetanka C. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes. Pancreas 2006, 32:231-243.
6. Brantly M., Wittes J., Vogelmeier C., Hubbard R., Fells G., Crystal R. Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes. Chest 1991, 100:703-708.
7. 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol 1985, 35:363-380.
8. Churg A., Dai J., Zay K., Karsan A., Hendricks R., Yee C., et al. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest 2001, 81:1119-1131.
9. Song S., Goudy K., Campbell-Thompson M., Wasserfall C., Scott-Jorgensen M., Wang J., et al. Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther 2004, 11:181-186.
10. Lewis E.C., Shapiro L., Bowers O.J., Dinarello C.A. Alpha 1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA 2005, 102:12153-12158.
11. Lewis E.C., Mizrahi M., Toledano M., DeFelice N., Wright J.L., Churg A., et al. Alpha 1-antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci USA 2008, 105:16236-16241.
12. Kalis M., Kumar R., Janciauskiene S., Salehi A., Cilio C.M. Alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic beta-cells. Islets 2010, 2:185-189.
13. Hamaguchi K., Gaskins H., Leiter E. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 1991, 40:842-849.
14. Sai P., Rivereau A., Granier C., Haertle T., Martignat L. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes. Clin Exp Immunol 1996, 105:330-337.
15. Barshes N.R., Wyllie S., Goss J.A. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005, 77:587-597.
16. Hering B.J., Kandaswamy R., Harmon J.V., Ansite J.D., Clemmings S.M., Sakai T., et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004, 4:390-401.
17. Liu C.Y., Noorchashm H., Sutter J.A., Naji M., Prak E.L., Boyer J., et al. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med 2007, 13:1295-1298.
18. Loganathan G., Dawra R.K., Pugazhenthi S., Wiseman A.C., Sanders M.A., Saluja A.K., et al. Culture of impure human islet fractions in the presence of alpha-1 antitrypsin prevents insulin cleavage and improves islet recovery. Transplant Proc 2010, 42:2055-2057.
19. Zhang B., Lu Y.Q., Campbell-Thompson M., Spencer T., Wasserfall C., Atkinson M., et al. Alpha 1-antitrypsin protects beta-cells from apoptosis. Diabetes 2007, 56:1316-1323.
20. Koulmanda M., Bhasin M., Hoffman L., Fan Z.G., Qipo A.D., Shi H., et al. Curative and beta cell regenerative effects of alpha 1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci USA 2008, 105:16242-16247.
21. Lewis E.C. Alpha-1-antitrypsin for protecting insulin producing beta cells in islet allograft transplantation and in the treatment of diabetes. Inflamm Res 2010, 59:S163.
22. Bottino R., Lemarchand P., Trucco M., Giannoukakis N. Gene-and cell-based therapeutics for type I diabetes mellitus. Gene Ther 2003, 10:875-889.
23. Hui H., Dotta F., Mario U.D., Perfetti R. Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J Cell Physiol 2004, 200:177-200.
24. Abecassis A., Ochayon D., Ozeri E., Mizrahi M.I., Kalay N., Sabag D., et al. Protection of insulin producing beta cells by the anti-inflammatory acute phase protein alpha-1-antitrypsin. Cytokine 2010, 52. 6.
25. + T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol 2009, 182:793-801.
26. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
27. Deknuydt F., Bioley G., Valmori D., Ayyoub M. IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol 2009, 131:298-307.
28. Osorio F., LeibundGut-Landmann S., Lochner M., Lahl K., Sparwasser T., Eberl G., et al. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 2008, 38:3274-3281.
29. Shahaf G., Moser H., Ozeri E., Mizrahi M., Abecassis A., Lewis E.C. α-1-Antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection. Mol Med 2011, 17:1000.
30. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007, 13:423-431.
31. Shoda L.K.M., Young D.L., Ramanujan S., Whiting C.C., Atkinson M.A., Bluestone J.A., et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005, 23:115-126.
32. Trembleau S., Adorini L., Germann T., Gately M.K. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 1995, 16:383-386.
33. O'Garra A., Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 2000, 10:542-550.
34. Schulz E.G., Mariani L., Radbruch A., Höfer T. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-γ and interleukin-12. Immunity 2009, 30:673-683.
35. Borriello F., Krauter K.S. Multiple murine alpha 1-protease inhibitor genes show unusual evolutionary divergence. Proc Natl Acad Sci USA 1991, 88:9417.
36. Ma H., Lu Y., Li H., Campbell-Thompson M., Parker M., Wasserfall C., et al. Intradermal α1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease. Diabetologia 2010, 53:2198-2204.